口腔癌围术期舌背喷雾 cetylpyridinium chloride(CPC)与气管抽吸物细菌:一项随机可行性研究
Perioperative cetylpyridinium chloride spray to the tongue dorsum and bacteria recovered from tracheal aspirates: a randomised feasibility study
单中心随机可行性试验将17例口腔癌切除重建患者分入0.3% cetylpyridinium chloride(CPC)舌背喷雾组或对照组,符合方案CPC组给药依从性184/184,无干预相关不良事件。
- Article
- Open access
- Published: 05 October 2026
- Yuki Sakai1,
- Hironori Sakai ORCID: orcid.org/0000-0002-4066-42371,
- Ryo Kajihara1,
- Kazunori Anzai1,
- Hiroki Otagiri1,
- Kota Yanai2 &
- …
- Hiroshi Kurita1
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
To assess the feasibility of a randomised trial of perioperative cetylpyridinium chloride (CPC) spray to the tongue dorsum in patients undergoing oral cancer resection and reconstruction, and to obtain preliminary, hypothesis-generating estimates of its effect on oral hygiene and on the bacterial profile of tracheal aspirates. This single-centre, randomised, parallel-group, open-label feasibility trial (UMIN000044932) allocated 17 patients to a 0.3% CPC tongue-dorsum spray or to a no-spray control arm. Feasibility outcomes were enrolment rate, adherence to the spray regimen, completeness of oral and tracheal-aspirate sampling, and safety. Preliminary efficacy outcomes were the Simplified Oral Hygiene Index (OHI-S) and tongue-coating score, and the bacterial load and amplicon sequence variants (ASVs, a measure of sequence-variant richness derived from 16S rRNA V3–V4 sequencing) recovered from oral samples and tracheal aspirates. Among the microbiological outcomes, the between-group difference in tracheal-aspirate ASV counts at extubation was treated as a key exploratory comparison. No imputed numerical ITT estimates were generated for postoperative oral-hygiene, oral microbiological, or tracheal-aspirate outcomes because some participants had structurally missing post-treatment values and no pre-specified imputation rule was available; these outcomes are therefore reported as outcome-specific evaluable-sample analyses. Of 17 randomised patients (9 CPC, 8 control), 14 were included in the per-protocol analysis (CPC n = 8; control n = 6); three patients were excluded after randomisation (two for reconstructive-flap necrosis, one for poor postoperative oral hygiene). Adherence in the per-protocol CPC group was complete (184/184 scheduled administrations across 8 participants). OHI-S and tongue-coating scores decreased significantly within the CPC group from baseline to postoperative day 7 (Wilcoxon signed-rank test, p = 0.042 and p = 0.018; unadjusted), but not within the control group; no significant between-group differences were detected at any time point. ASVs in tracheal aspirates were numerically lower in the CPC group, but the between-group difference did not reach statistical significance (Mann–Whitney U test, p = 0.073). Post-extubation tracheal-aspirate outcomes are reported for the corresponding evaluable-sample sets. Postoperative pneumonia occurred in one control patient and no surgical-site infections were observed; the trial was not designed or powered for these clinical endpoints. In this small, exploratory feasibility trial, perioperative CPC tongue-dorsum spray was deliverable within routine perioperative care, with complete recorded administration in the per-protocol CPC cohort and no recorded intervention-related adverse events. The findings provide preliminary, hypothesis-generating signals regarding oral hygiene and the bacterial profile of tracheal aspirates, but do not support any inference of clinical efficacy for the prevention of postoperative pneumonia. An adequately powered multicentre randomised trial is required.
Acknowledgements
The authors used Claude (Anthropic, 2024), an AI-based conversational assistant, to assist in generating R code for statistical analysis in this study. All generated code was reviewed, tested, and validated by the authors, who take full responsibility for the analytical results presented in this manuscript.
Funding
This research received no external funding.
Author information
Authors and Affiliations
Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, 3-1-C1, Asahi, Matsumoto, Nagano, Matsumoto, 390-8621, Japan
Yuki Sakai, Hironori Sakai, Ryo Kajihara, Kazunori Anzai, Hiroki Otagiri & Hiroshi Kurita
Sunstar Inc. R&D, 3-1, Asahimachi, Takatsuki, Osaka, 569-1134, Japan
Kota Yanai
Authors
- Yuki Sakai
- Hironori Sakai
- Ryo Kajihara
- Kazunori Anzai
- Hiroki Otagiri
- Kota Yanai
- Hiroshi Kurita
Corresponding author
Correspondence to Hironori Sakai.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics
This research was conducted in collaboration with Sunstar Inc. The bacteriological analyses (DNA extraction, qPCR and 16S rRNA sequencing) were performed by Sunstar Inc.; the laboratory personnel were blinded to group allocation, with unblinding only at the stage of statistical analysis after dataset lock. Kota Yanai is an employee of Sunstar Inc., which manufactures the CPC product (G·U·M Medical Spray A) used in this study. The remaining authors declare no conflicts of interest. The decisions on study design, conduct, analytical approach, interpretation and decision to publish were made by the academic investigators.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Sakai, Y., Sakai, H., Kajihara, R. et al. Perioperative cetylpyridinium chloride spray to the tongue dorsum and bacteria recovered from tracheal aspirates: a randomised feasibility study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-73106-5
Received: 25 April 2026
Accepted: 21 September 2026
Published: 05 October 2026
DOI: https://doi.org/10.1038/s41598-026-73106-5
Keywords
来源:Nature 健康护理主题 · nature.com